In this issue:
Corticosteroids + leflunomide treats IgG4-related disease
Early TNFi therapy restores work ability in RA patients
Ixekizumab effective in active psoriatic arthritis
Lifetime risk of hand OA nearly 40%
NSAIDs not worthwhile in spinal pain
Disability & pain in early RA: no difference between the 1990s & 2000s?
Prucalopride shows promise for treating dismotility symptoms
Corticosteroids impact gonadal function in men with SLE
Immunosuppressants: modest benefit in early diffuse cutaneous SSc
Triple therapy retains a place as a therapeutic strategy for RA
Please login below to download this issue (PDF)